Sonoma Pharmaceuticals Inc. (SNOA)
SNOA trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1367083/000168316826004871/0001683168-26-004871-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | SNOA on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2007 |
| SEC CIK | 0001367083 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $19.5M |
| Net income | -$3.2M |
| Operating income | -$2.5M |
| Net margin | -16.3% |
| Operating margin | -12.6% |
| Revenue growth | +36.7% |
| Cash | $2.4M |
| Total assets | $14.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $4.6M cash; operating cash flow -$667K a quarter. | Report 2026-09-30 |
| Shares outstanding | 5,061,593 (2026-11-10); 1,701,076 a year earlier; 13,679,333 three years earlier. 3y figure adjusted for splits (1-for-20 overall). | Cover page 2026-11-10 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2024-08-30 | Source 2024-08-30 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-06-18 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Frazier & Deeter, LLC, Nashville, Tennessee, United States | PCAOB Form AP 2026-07-07 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-30 | $7.2M | -$66K | -$736K | $4.6M | $57K | $23.5M | 10-Q 2026-11-10 |
| Q1 2027 2026-06-30 | $6.4M | -$330K | -$649K | $5.3M | $140K | $21.9M | 10-Q 2026-08-06 |
| Q4 2026 2026-03-31 | $5.6M | -$581K | -$519K | $2.4M | $222K | $19.5M | 10-K 2026-06-16 |
| Q3 2026 2025-12-31 | $4.3M | -$819K | -$764K | $2.6M | $0 | $17.7M | 10-Q 2026-02-10 |
| Q2 2026 2025-09-30 | $5.6M | -$534K | -$635K | $3.0M | $56K | $16.9M | 10-Q 2026-11-10 |
| Q1 2026 2025-06-30 | $4.0M | -$1.2M | -$2.0M | $3.6M | $139K | $14.9M | 10-Q 2026-08-06 |
| Q4 2025 2025-03-31 | $3.8M | -$776K | -$95K | $5.4M | $220K | $14.3M | 10-K 2026-06-16 |
| Q3 2025 2024-12-31 | $3.6M | -$928K | $565K | $5.2M | $0 | $14.0M | 10-Q 2026-02-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2026-11-13 |
| Latest annual report FORM 10-K FOR MAR 2026 | 10-K | 2026-06-16 |
| Latest quarterly / interim FORM 10-Q FOR SEP 2026 | 10-Q | 2026-11-10 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-06 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-07-28 |
Source: SEC EDGAR submissions feed, 979 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.8% |
| 1 month | -7.6% |
| 3 months | -18.7% |
| Year to date | -70.1% |
| 1 year | -69.2% |
| From 52-week high | -71.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
| NVNO | enVVeno Medical Corporation | $5.95 | -3.65% | $4.1M |
| INBS | Intelligent Bio Solutions Inc. | $1.50 | -16.20% | $5.0M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| NMTC | NeuroOne Medical Technologies Corporation | $0.7450 | -0.01% | $6.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier